Stephen Liu: The role of adjuvant chemotherapy when adjuvant ALK TKI is planned
Stephen Liu shared a post on X:
“Dr. Joshua Reuss takes center stage at DC Lung 24 to debate Marina Garassino on the role of adjuvant chemotherapy when adjuvant ALK TKI is planned. Join us Saturday, October 19th in downtown Washington, DC for this IASLC endorsed, one-day CME meeting!”
Read Further.
Source: Stephen Liu/X
For more posts about DC Lung 24 by Stephen Liu, visit oncodaily.com
Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.
As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023